Tavros Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50.4M

Tavros Therapeutics General Information

Description

Developer of oncological drugs designed to treat cancer. The company's drug can impact oncology therapy by uncovering vulnerabilities within the tumor and placing the right drug with the right combination, enabling patients to get cured of oncological disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8 Davis Drive
  • Suite 100
  • Durham, NC 27709
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 8 Davis Drive
  • Suite 100
  • Durham, NC 27709
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tavros Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 23-Dec-2024 $50.4M Completed Generating Revenue
2. Seed Round 27-Sep-2022 Completed Clinical Trials - General
1. Seed Round 17-Mar-2020 $3M $3M Completed Clinical Trials - General
To view Tavros Therapeutics’s complete valuation and funding history, request access »

Tavros Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Tavros Therapeutics’s complete cap table history, request access »

Tavros Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncological drugs designed to treat cancer. The company's drug can impact oncology therapy by uncovering vu
Drug Discovery
Durham, NC
22 As of 2025

Cerdanyola, Spain
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tavros Therapeutics Competitors (60)

One of Tavros Therapeutics’s 60 competitors is Ability Pharma, a Private Equity-Backed company based in Cerdanyola, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Invectys Venture Capital-Backed Houston, TX
Cirius Therapeutics Venture Capital-Backed Grand Rapids, MI
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Dragonfly (Drug Discovery) Venture Capital-Backed Waltham, MA
You’re viewing 5 of 60 competitors. Get the full list »

Tavros Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tavros Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
KdT Ventures Venture Capital Minority
Piedmont Capital Investments Venture Capital Minority
To view Tavros Therapeutics’s complete investors history, request access »

Tavros Therapeutics FAQs

  • When was Tavros Therapeutics founded?

    Tavros Therapeutics was founded in 2019.

  • Where is Tavros Therapeutics headquartered?

    Tavros Therapeutics is headquartered in Durham, NC.

  • What is the size of Tavros Therapeutics?

    Tavros Therapeutics has 22 total employees.

  • What industry is Tavros Therapeutics in?

    Tavros Therapeutics’s primary industry is Drug Discovery.

  • Is Tavros Therapeutics a private or public company?

    Tavros Therapeutics is a Private company.

  • What is the current valuation of Tavros Therapeutics?

    The current valuation of Tavros Therapeutics is .

  • What is Tavros Therapeutics’s current revenue?

    The current revenue for Tavros Therapeutics is .

  • How much funding has Tavros Therapeutics raised over time?

    Tavros Therapeutics has raised $10.5M.

  • Who are Tavros Therapeutics’s investors?

    Alexandria Venture Investments, KdT Ventures, and Piedmont Capital Investments have invested in Tavros Therapeutics.

  • Who are Tavros Therapeutics’s competitors?

    Ability Pharma, Invectys, Cirius Therapeutics, Inovio Pharmaceuticals, and Dragonfly (Drug Discovery) are some of the 60 competitors of Tavros Therapeutics.

  • When was Tavros Therapeutics acquired?

    Tavros Therapeutics was acquired on 23-Dec-2024.

  • Who acquired Tavros Therapeutics?

    Tavros Therapeutics was acquired by Vividion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process